Alic et al. [102] investigated the role of β-secretase (BACE) in patients with Down syndrome (DS) with AD, revealing that the β-secretase activity of BACE1 correlates directly with αβ levels, whereas BACE2 activity does not. The gene discussed is BACE1; the disease is Alzheimer disease.